Healthcare provider profile · identity verified

Johnna Mantineo, D.O.

Family Practice · PORT ORANGE, FL · NPI 1952371312

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	626	231
Levothyroxine Sodium	Levothyroxine Sodium	535	191
Losartan Potassium	Losartan Potassium	385	140
Amlodipine Besylate	Amlodipine Besylate	376	144
Lisinopril	Lisinopril	296	112
Metformin Hcl	Metformin Hcl	280	101
Rosuvastatin Calcium	Rosuvastatin Calcium	261	101
Hydrochlorothiazide	Hydrochlorothiazide	212	80
Pantoprazole Sodium	Pantoprazole Sodium	178	72
Alprazolam	Alprazolam	176	52
Omeprazole	Omeprazole	165	64
Gabapentin	Gabapentin	163	63
Montelukast Sodium	Montelukast Sodium	160	53
Metoprolol Succinate	Metoprolol Succinate	146	55
Simvastatin	Simvastatin	145	51
Trazodone Hcl	Trazodone Hcl	129	47
Zolpidem Tartrate	Zolpidem Tartrate	115	35
Furosemide	Furosemide	102	39
Metoprolol Tartrate	Metoprolol Tartrate	102	35
Sertraline Hcl	Sertraline Hcl	102	41
Escitalopram Oxalate	Escitalopram Oxalate	101	42
Ozempic	Semaglutide	93	22
Pravastatin Sodium	Pravastatin Sodium	90	31
Baclofen	Baclofen	79	23
Allopurinol	Allopurinol	78	26
Lorazepam	Lorazepam	73	19
Duloxetine Hcl	Duloxetine Hcl	72	24
Famotidine	Famotidine	72	33
Potassium Chloride	Potassium Chloride	72	25
Albuterol Sulfate Hfa	Albuterol Sulfate	71	30
Fluticasone Propionate	Fluticasone Propionate	69	29
Synthroid	Levothyroxine Sodium	67	22
Tamsulosin Hcl	Tamsulosin Hcl	66	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	22
Eliquis	Apixaban	58	16
Mounjaro	Tirzepatide	58	12
Meloxicam	Meloxicam	54	19
Methylprednisolone	Methylprednisolone	53	52
Citalopram Hbr	Citalopram Hydrobromide	50	19
Januvia	Sitagliptin Phosphate	47	11
Chlorthalidone	Chlorthalidone	46	20
Ezetimibe	Ezetimibe	46	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	16
Alendronate Sodium	Alendronate Sodium	44	16
Esomeprazole Magnesium	Esomeprazole Magnesium	42	suppressed
Pregabalin	Pregabalin	42	15
Rybelsus	Semaglutide	42	12
Atenolol	Atenolol	41	13
Lovastatin	Lovastatin	39	13
Paroxetine Hcl	Paroxetine Hcl	39	17
Temazepam	Temazepam	39	suppressed
Buspirone Hcl	Buspirone Hcl	38	14
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	38	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	15
Clopidogrel	Clopidogrel Bisulfate	36	13
Jardiance	Empagliflozin	36	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	36	14
Diclofenac Sodium	Diclofenac Sodium	35	11
Azelastine Hcl	Azelastine Hcl	34	14
Celecoxib	Celecoxib	32	12
Fenofibrate	Fenofibrate	31	suppressed
Clonazepam	Clonazepam	30	11
Tizanidine Hcl	Tizanidine Hcl	30	12
Valsartan	Valsartan	29	suppressed
Finasteride	Finasteride	28	11
Venlafaxine Hcl Er	Venlafaxine Hcl	28	11
Benazepril Hcl	Benazepril Hcl	27	suppressed
Glimepiride	Glimepiride	27	11
Glipizide Er	Glipizide	27	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	27	suppressed
Bupropion Xl	Bupropion Hcl	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	24	suppressed
Carvedilol	Carvedilol	23	11
Metformin Hcl Er	Metformin Hcl	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Tramadol Hcl	Tramadol Hcl	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	21
Ibuprofen	Ibuprofen	22	suppressed
Nebivolol Hcl	Nebivolol Hcl	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	22
Clonidine Hcl	Clonidine Hcl	21	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	12
Ipratropium Bromide	Ipratropium Bromide	20	suppressed
Azithromycin	Azithromycin	19	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Mupirocin	Mupirocin	19	15
Topiramate	Topiramate	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	18	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	12
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	14
Donepezil Hcl	Donepezil Hcl	17	suppressed
Estradiol	Estradiol	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Diazepam	Diazepam	16	12
Acyclovir	Acyclovir	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	15	suppressed
Desloratadine	Desloratadine	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Raloxifene Hcl	Raloxifene Hcl	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Azelastine-Fluticasone	Azelastine/Fluticasone	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Glipizide	Glipizide	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	12
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Prednisone	Prednisone	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error